Vaxart, Inc.

80
Strong Buy
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US92243A2006
USD
0.72
0.04 (5.96%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Vaxart, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
16.00
-66.00
-82.00
-107.00
-70.00
-31.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-22.00
3.00
-10.00
-4.00
-2.00
2.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
7.00
-44.00
-70.00
-94.00
-59.00
-23.00
Cash Flow from Investing Activities
16.00
-21.00
43.00
-20.00
-49.00
-1.00
Cash Flow from Financing Activities
4.00
56.00
15.00
17.00
125.00
138.00
Net Cash Inflow / Outflow
28.00
-9.00
-11.00
-97.00
16.00
113.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Vaxart, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
16.803
-47.047
63.00
135.72%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-22.563
2.284
-24.00
-1087.87%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
7.714
-41.767
48.00
118.47%
Cash Flow from Investing Activities
16.632
0
16.00
0.00%
Cash Flow from Financing Activities
4.239
31.227
-27.00
-86.43%
Net Cash Inflow / Outflow
28.585
-10.54
38.00
371.20%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is 117.23% vs 36.46% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
7.71
-44.76
117.23%